Scientists have invented an all-in-one injection that could eventually enable children to receive all of their vaccines in a single shot.
GlaxoSmithKline's shingles vaccine Shingrix won unanimous approval from an advisory panel to the U.S. Food and Drug Administration (FDA), paving the way for the first alternative to Merck's Zostavax.
The American Academy of Pediatrics (AAP) is recommending against the FluMist nasal spray flu vaccine for the second year in a row due to poor effectiveness.
While 60% of parents are vaccinating their teenagers against human papillomavirus (HPV), only 43% are up-to-date on all of the recommended doses of the vaccine, according to U.S. health officials.
A new study in Australia has found no evidence of an increased risk of febrile seizures when the combination vaccine MMRV is given for the 2nd dose in the measles-mumps-rubella (MMR) immunization series.
A group of 18 people from 11 states have filed a lawsuit against Merck & Co. for failing to warn about risks of the Zostavax shingles vaccines.
Data from a Phase I clinical trial has shown promising results for a painless needle-free flu vaccine patch compared to a flu shot injection.
Merck & Co. is facing a growing number of lawsuits for downplaying the risk of developing shingles and other side effects from the Zostavax shingles vaccine.
Manipulating a protein of the hepatitis C virus (HCV) in a way that exposes it to a direct attack by the immune system may help lead to a preventative vaccine, according to a new study.
After a person who got the vaccine died, health officials in Australia remind doctors not to give Merck's shingles vaccine Zostavax to patients who are sick or on medications that weaken the immune system.